Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2024-04-01 00:00:00 ET · period of report 2024-03-28 · accession 0001048477-24-000054 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-01 | 2024-03-28 | BMRN | Davis George Eric | EVP, CLO | S - Sale | $88.34 | -24.6K | 55.9K | -31% | -$2.17M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-28 | S | D | 24,602 | $88.34 | 55,856 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on September 13, 2023. |